View in EDS

Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial.

Saved in:
Bibliographic Details
Title: Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial.
Authors: Le Gouill S; Service d'hématologie clinique du Centre Hospitalier Universitaire (CHU) de Nantes, INSERM Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA) Nantes-Angers, Nantes Excellence Trajectory (NeXT) Université de Nantes, Nantes, France., Morschhauser F; CHU Lille, Université de Lille, Lille, France., Chiron D; INSERM, CNRS, Université de Nantes, Nantes, France., Bouabdallah K; CHU Bordeaux, Bordeaux, France., Cartron G; CHU Montpellier, Institut de Génétique Moléculaire de Montpellier, INSERM, Université de Montpellier, Montpellier, France., Casasnovas O; CHU Dijon, INSERM, Dijon, France., Bodet-Milin C; Service de médecine nucléaire CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France., Ragot S; Université de Bourgogne Faculté de Médecine, INSERM, CHU Dijon, Dijon, France., Bossard C; Service d'anatomopathologie, CHU de Nantes, Nantes, France., Nadal N; CHU Dijon, INSERM, Dijon, France., Herbaux C; CHU Lille, Lille, France., Tessoulin B; Service d'hématologie clinique du Centre Hospitalier Universitaire (CHU) de Nantes, INSERM Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA) Nantes-Angers, Nantes Excellence Trajectory (NeXT) Université de Nantes, Nantes, France., Tchernonog E; CHU Montpellier, Montpellier, France., Rossi C; CHU Dijon, INSERM, Dijon, France., McCulloch R; Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom; and., Gastinne T; Service d'hématologie clinique du CHU de Nantes, Nantes, France., Callanan MB; Université de Bourgogne Faculté de Médecine, INSERM, CHU Dijon, Dijon, France., Rule S; Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom; and.
Source: Blood [Blood] 2021 Feb 18; Vol. 137 (7), pp. 877-887.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33181832
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Le+Gouill+S%22">Le Gouill S</searchLink>; Service d'hématologie clinique du Centre Hospitalier Universitaire (CHU) de Nantes, INSERM Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA) Nantes-Angers, Nantes Excellence Trajectory (NeXT) Université de Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Morschhauser+F%22">Morschhauser F</searchLink>; CHU Lille, Université de Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Chiron+D%22">Chiron D</searchLink>; INSERM, CNRS, Université de Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Bouabdallah+K%22">Bouabdallah K</searchLink>; CHU Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Cartron+G%22">Cartron G</searchLink>; CHU Montpellier, Institut de Génétique Moléculaire de Montpellier, INSERM, Université de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Casasnovas+O%22">Casasnovas O</searchLink>; CHU Dijon, INSERM, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Bodet-Milin+C%22">Bodet-Milin C</searchLink>; Service de médecine nucléaire CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Ragot+S%22">Ragot S</searchLink>; Université de Bourgogne Faculté de Médecine, INSERM, CHU Dijon, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Bossard+C%22">Bossard C</searchLink>; Service d'anatomopathologie, CHU de Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Nadal+N%22">Nadal N</searchLink>; CHU Dijon, INSERM, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Herbaux+C%22">Herbaux C</searchLink>; CHU Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Tessoulin+B%22">Tessoulin B</searchLink>; Service d'hématologie clinique du Centre Hospitalier Universitaire (CHU) de Nantes, INSERM Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA) Nantes-Angers, Nantes Excellence Trajectory (NeXT) Université de Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Tchernonog+E%22">Tchernonog E</searchLink>; CHU Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Rossi+C%22">Rossi C</searchLink>; CHU Dijon, INSERM, Dijon, France.<br /><searchLink fieldCode="AU" term="%22McCulloch+R%22">McCulloch R</searchLink>; Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom; and.<br /><searchLink fieldCode="AU" term="%22Gastinne+T%22">Gastinne T</searchLink>; Service d'hématologie clinique du CHU de Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Callanan+MB%22">Callanan MB</searchLink>; Université de Bourgogne Faculté de Médecine, INSERM, CHU Dijon, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Rule+S%22">Rule S</searchLink>; Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom; and.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2021 Feb 18; Vol. 137 (7), pp. 877-887.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33181832
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2020008727
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 877
    Titles:
      – TitleFull: Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Le Gouill S
      – PersonEntity:
          Name:
            NameFull: Morschhauser F
      – PersonEntity:
          Name:
            NameFull: Chiron D
      – PersonEntity:
          Name:
            NameFull: Bouabdallah K
      – PersonEntity:
          Name:
            NameFull: Cartron G
      – PersonEntity:
          Name:
            NameFull: Casasnovas O
      – PersonEntity:
          Name:
            NameFull: Bodet-Milin C
      – PersonEntity:
          Name:
            NameFull: Ragot S
      – PersonEntity:
          Name:
            NameFull: Bossard C
      – PersonEntity:
          Name:
            NameFull: Nadal N
      – PersonEntity:
          Name:
            NameFull: Herbaux C
      – PersonEntity:
          Name:
            NameFull: Tessoulin B
      – PersonEntity:
          Name:
            NameFull: Tchernonog E
      – PersonEntity:
          Name:
            NameFull: Rossi C
      – PersonEntity:
          Name:
            NameFull: McCulloch R
      – PersonEntity:
          Name:
            NameFull: Gastinne T
      – PersonEntity:
          Name:
            NameFull: Callanan MB
      – PersonEntity:
          Name:
            NameFull: Rule S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 02
              Text: 2021 Feb 18
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 137
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1